| | |
Assessment Periods
|
p-values
|
|---|
| |
Treatment Group
|
Baseline
|
4 months
|
1 year
|
2 years
|
Treatment Group
|
Time
|
Treatment Group x Time
|
|---|
|
≥250 min/week of bout-related MVPA
|
Control
|
81 (40.3%)
|
83 (43.2%)
|
65 (40.0%)
|
63 (41.5%)
|
0.2949
|
0.4872
|
0.1460
|
|
Small Change
|
74 (37.2%)
|
82 (45.6%)
|
67 (44.7%)
|
56 (37.6%)
|
|
Large Change
|
88 (45.1%)
|
98 (55.4%)
|
65 (40.9%)
|
71 (46.7%)
|
|
Increase daily steps by ≥2000 steps/day
|
Control
|
–
|
32 (16.7%)
|
25 (15.3%)
|
31 (20.4%)
|
0.1859
|
0.5124
|
0.8087
|
|
Small Change
|
–
|
44 (24.4%)
|
39 (26.0%)
|
34 (22.8%)
|
|
Large Change
|
–
|
40 (22.6%)
|
35 (22.0%)
|
32 (21.1%)
|
- N (%); Models adjusted for clinic, gender, race, armband wear time, and baseline value of outcome measure
